Your browser doesn't support javascript.
loading
Safety evaluation of substituting clopidogrel for ticlopidine in Japanese patients with ischemic stroke--Hiroshima ticlopidine, clopidogrel safe exchange trial.
Kohriyama, Tatsuo; Mihara, Chie; Yokoyama, Takakazu; Torii, Tsuyoshi; Yamada, Atsuo; Takamatsu, Kazuhiro; Ota, Taisei; Noda, Kouichi; Kataoka, Satoshi; Ito, Hijiri; Nomura, Eiichi; Ohtsuki, Toshiho; Aoki, Shiro; Nezu, Tomohisa; Takeda, Ikuko; Mukai, Tomoya; Hosomi, Naohisa; Matsumoto, Masayasu.
Affiliation
  • Kohriyama T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Mihara C; Department of Neurosurgery, Yokoyama Hospital, Kure, Japan.
  • Yokoyama T; Department of Neurosurgery, Yokoyama Hospital, Kure, Japan.
  • Torii T; Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Yamada A; Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Takamatsu K; Department of Neurology, Brain Attack Center Ota Memorial Hospital, Fukuyama, Japan.
  • Ota T; Department of Neurology, Brain Attack Center Ota Memorial Hospital, Fukuyama, Japan.
  • Noda K; Department of Neurology, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan.
  • Kataoka S; Department of Neurology, Chugoku Rousai Hospital, Kure, Japan.
  • Ito H; Department of Neurology, Mifukai Vihara Hananosato Hospital, Miyoshi, Japan.
  • Nomura E; Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
  • Ohtsuki T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Aoki S; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Nezu T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Takeda I; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Mukai T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Hosomi N; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. Electronic address: nhosomi@hiroshima-u.ac.jp.
  • Matsumoto M; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
J Stroke Cerebrovasc Dis ; 23(6): 1485-90, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24560246

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ticlopidine / Brain Ischemia / Stroke / Drug Substitution / Fibrinolytic Agents / Hemorrhage Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Stroke Cerebrovasc Dis Journal subject: ANGIOLOGIA / CEREBRO Year: 2014 Document type: Article Affiliation country: Japan Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ticlopidine / Brain Ischemia / Stroke / Drug Substitution / Fibrinolytic Agents / Hemorrhage Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Stroke Cerebrovasc Dis Journal subject: ANGIOLOGIA / CEREBRO Year: 2014 Document type: Article Affiliation country: Japan Country of publication: United States